Bio-Rad is a global leader in non-animal derived recombinant monoclonal antibodies, supporting drug discovery and bioanalysis. With 20+ years of expertise and 60,000+ antibodies generated; we provide high-quality antibodies for diverse applications. Our Pioneer Antibody Discovery Platform delivers optimized antibody drug candidates with superior affinity and developability in industry-leading timelines.